Follow
Tihana Bicanic
Title
Cited by
Cited by
Year
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10285), 1637, 2021
2052*2021
Cryptococcal meningitis
T Bicanic, TS Harrison
British medical bulletin 72 (1), 99-118, 2004
6442004
Cryptococcus: from environmental saprophyte to global pathogen
RC May, NRH Stone, DL Wiesner, T Bicanic, K Nielsen
Nature Reviews Microbiology 14 (2), 106-117, 2016
5442016
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ...
Medrxiv, 2021.06. 15.21258542, 2021
492*2021
Tackling the emerging threat of antifungal resistance to human health
MC Fisher, A Alastruey-Izquierdo, J Berman, T Bicanic, EM Bignell, ...
Nature reviews microbiology 20 (9), 557-571, 2022
4702022
Liposomal Amphotericin B (AmBisome«): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
NRH Stone, T Bicanic, R Salim, W Hope
Drugs 76, 485-500, 2016
4632016
Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes
JN Jarvis, T Bicanic, A Loyse, D Namarika, A Jackson, JC Nussbaum, ...
Clinical infectious diseases 58 (5), 736-745, 2014
3912014
Antifungal combinations for treatment of cryptococcal meningitis in Africa
SF Molloy, C Kanyama, RS Heyderman, A Loyse, C Kouanfack, ...
New England Journal of Medicine 378 (11), 1004-1017, 2018
3802018
Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B orá…
T Bicanic, G Meintjes, R Wood, M Hayes, K Rebe, LG Bekker, T Harrison
Clinical infectious diseases 45 (1), 76-80, 2007
3382007
Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial
JN Jarvis, G Meintjes, K Rebe, GN Williams, T Bicanic, A Williams, ...
Aids 26 (9), 1105-1113, 2012
3052012
Cryptococcosis diagnosis and treatment: What do we know now
JR Perfect, T Bicanic
Fungal Genetics and Biology 78, 49-54, 2015
2972015
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial
T Bicanic, R Wood, G Meintjes, K Rebe, A Brouwer, A Loyse, LG Bekker, ...
Clinical infectious diseases 47 (1), 123-130, 2008
2882008
The case for adopting the “species complex” nomenclature for the etiologic agents of cryptococcosis
KJ Kwon-Chung, JE Bennett, BL Wickes, W Meyer, CA Cuomo, ...
MSphere 2 (1), 10.1128/msphere. 00357-16, 2017
2822017
Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution
T Bicanic, T Harrison, A Niepieklo, N Dyakopu, G Meintjes
Clinical Infectious Diseases 43 (8), 1069-1070, 2006
2792006
Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients
T Bicanic, C Muzoora, AE Brouwer, G Meintjes, N Longley, K Taseera, ...
Clinical infectious diseases 49 (5), 702-709, 2009
2432009
Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study
T Bicanic, G Meintjes, K Rebe, A Williams, A Loyse, R Wood, M Hayes, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (2), 130-134, 2009
2372009
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ...
The Lancet 400 (10349), 359-368, 2022
2362022
Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures
T Bicanic, AE Brouwer, G Meintjes, K Rebe, D Limmathurotsakul, ...
Aids 23 (6), 701-706, 2009
2312009
Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries
A Loyse, H Thangaraj, P Easterbrook, N Ford, M Roy, T Chiller, ...
The Lancet infectious diseases 13 (7), 629-637, 2013
1972013
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
DJ Ahern, Z Ai, M Ainsworth, C Allan, A Allcock, B Angus, MA Ansari, ...
Cell 185 (5), 916-938. e58, 2022
1752022
The system can't perform the operation now. Try again later.
Articles 1–20